Ghosh, Subrata K.
Lazarus, Douglas
Robertson, Neil
Liu, Qiyong P.
Kenyon, Elizabeth
Mallett, Christian L.
Chen, Ming
Medarova, Zdravka
Moore, Anna https://orcid.org/0000-0002-5218-7204
Funding for this research was provided by:
National Cancer Institute (1R44CA257093)
Article History
Received: 20 August 2025
Revised: 14 January 2026
Accepted: 2 February 2026
First Online: 19 February 2026
Declarations
:
: Animal studies were approved by the Institutional Animal Care and Use Committee at Michigan State University and are in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All applicable institutional and/or national guidelines for the care and use of animals were followed.
: S.K.G, N. R., Q.P.L and Z.M. are employees of TransCode Therapeutics, Inc. A.M. and Z.M. are the co-founders and shareholder of the company. S. K. G. and Q. P. L. have filed patent applications related to the manuscript as inventors: application no. PCT/US2021/065580 and application no. 63/356/449 (provisional application); both assigned to TransCode Therapeutics, Inc. D.L., E.K., C.L.M and M.C. declare no competing interests.